PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400

POZEN

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: PN400

Study type: Interventional

Funder types: Industry

Identifiers

NCT00599404

PN400-111

Details and patient eligibility

About

Pharmacokinetic study in healthy subjects with single and repeat b.i.d. dosing of PN 400 tablets from the same drug product batch.

Enrollment: 18 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Healthy male or non-pregnant female subjects between 18-55 years of age as well as other standard inclusion criteria for a study of this nature

Exclusion criteria

Standard inclusion criteria for a study of this nature

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)